Attendees at the 2025 APA Annual Meeting are excited to connect with peers and experts, exploring lifestyle medicine and networking opportunities for career growth.
Angelo Chaia, MD
Advertisement
Dr Chaia is a PGY-2 resident at Mount Sinai Beth Israel in New York City.
Articles by Angelo Chaia, MD
Angelo Chaia, MD, explores the impact of long-acting injectables on patients with severe mental illness and substance use disorders at the 2025 APA Annual Meeting.
Advertisement
Latest Updated Articles
Serious Mental Illness, Substance Use Disorders, and Long-Acting Injectables in the Emergency SettingPublished: May 18th 2025 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Evidence-Based Psychotherapy and Psychopharmacology for Mood Disorders: A Conversation With Holly A. Swartz, MD
2
Can the Initial Antipsychotic Influence Years of Weight Gain?
3
New Post-Hoc Analysis: Ingrezza 40 mg Leads to Clinically Meaningful Improvements in Tardive Dyskinesia Symptoms
4
Reflections on Developments in Correctional Psychiatry, with Tony Tamburello, MD
5
